Such changes could reduce the transamination activity, as suggested by an interference with the formation of diaminovalerate, a proposed metabolic intermediate in this catalytic reaction of GSAAT ( In light of experimental evidence showing the different monomeric and dimeric states of the Cys substitution mutants compared to GSAAT(WT), we propose that Cys168 and Cys190 are cruical for the protein activity and likely function as redox-active residues
This is not the traditional way that the FDA goes about doing stuff, they typically go through phase one trials, phase two trials, phase three trials, and that takes years, says Dr
Results suggest it may influence gene expression that helps control abnormal growth, though this research is still early and exploratory
See the published research at PubMed: Pickart & Margolina, Regenerative and protective actions of GHK-Cu (PMID 29954124)
Topical cosmetic use is common and has a strong safety record, while injectable forms are compounded and remain under active FDA review
Tailoring interventions to individual needs and conditions is crucial in managing the side effects of cancer treatment effectively
